Follow
Félix Gutiérrez Rodero
Félix Gutiérrez Rodero
Hospital Universitario de Elche & Universidad Miguel Hernández, Alicante, Spain
Verified email at gva.es - Homepage
Title
Cited by
Cited by
Year
Repurposed antiviral drugs for COVID-19—interim WHO SOLIDARITY trial results
WHO Solidarity Trial Consortium
New England journal of medicine 384 (6), 497-511, 2021
26562021
HLA-B*5701 screening for hypersensitivity to abacavir
S Mallal, E Phillips, G Carosi, PS Team
N Engl J Med 358 (6), 568-79, 2008
21422008
Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy
AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, J Van Lunzen, ...
Jama 316 (2), 171-181, 2016
17092016
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of …
AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, O Degen, ...
The Lancet 393 (10189), 2428-2438, 2019
10362019
Dolutegravir plus abacavir–lamivudine for the treatment of HIV-1 infection
SL Walmsley, A Antela, N Clumeck, D Duiculescu, A Eberhard, ...
New England Journal of Medicine 369 (19), 1807-1818, 2013
10082013
Maraviroc for previously treated patients with R5 HIV-1 infection
RM Gulick, J Lalezari, J Goodrich, N Clumeck, E DeJesus, A Horban, ...
New England Journal of Medicine 359 (14), 1429-1441, 2008
9112008
The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals.
HIVC Collaboration
AIDS 24 (1), 123-37., 2010
5492010
Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial
DA Margolis, J Gonzalez-Garcia, HJ Stellbrink, JJ Eron, Y Yazdanpanah, ...
The Lancet 390 (10101), 1499-1510, 2017
5072017
Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques.
OBKL Said MA, Johnson HL, Nonyane BA, Deloria-Knoll M
PLoS One 8 (4), e60273, 2013
4822013
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 A Meta-analysis
WHOREA COVID
JAMA-Journal of the American Medical Association 326 (6), 499-518, 2021
4732021
Antifungal drug resistance to azoles and polyenes
MM Canuto, FG Rodero
The Lancet infectious diseases 2 (9), 550-563, 2002
4312002
Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection
G Fätkenheuer, M Nelson, A Lazzarin, I Konourina, AIM Hoepelman, ...
New England Journal of Medicine 359 (14), 1442-1455, 2008
4242008
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
J Berenguer, P Ryan, J Rodriguez-Bano, I Jarrín, J Carratala, J Pachón, ...
Clinical Microbiology and Infection 26 (11), 1525-1536, 2020
3592020
Evaluation of the Immunochromatographic Binax NOW Assay for Detection of Streptococcus pneumoniae Urinary Antigen in a Prospective Study of Community …
F Gutiérrez, M Mar, JC Rodríguez, A Ayelo, B Soldán, L Cebrián, C Mirete, ...
Clinical Infectious Diseases 36 (3), 286-292, 2003
3442003
When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study.
HIVC Collaboration
Ann Intern Med. 154 (8), 509-15, 2011
3422011
Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index
M Masia, F Gutierrez, C Shum, S Padilla, JC Navarro, E Flores, ...
Chest 128 (4), 2223-2229, 2005
3112005
Prediction of neuropsychiatric adverse events associated with long-term efavirenz therapy, using plasma drug level monitoring
F Gutiérrez, A Navarro, S Padilla, R Antón, M Masiá, J Borrás, ...
Clinical infectious diseases 41 (11), 1648-1653, 2005
2872005
The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens
F Gutiérrez, M Masiá, C Mirete, B Soldán, JC Rodríguez, S Padilla, ...
Journal of infection 53 (3), 166-174, 2006
2732006
Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study
E Martinez, M Larrousse, JM Llibre, F Gutierrez, M Saumoy, A Antela, ...
Aids 24 (11), 1697-1707, 2010
2402010
Microbiology and outcome of iliopsoas abscess in 124 patients
VN López, JM Ramos, V Meseguer, JLP Arellano, R Serrano, ...
Medicine 88 (2), 120-130, 2009
2182009
The system can't perform the operation now. Try again later.
Articles 1–20